|
|
Objectives & Strategy
Ardana is committed to improved reproductive health, which is central to our well-being and fundamental to our future. Objectives
Ardana intends to:
- Be a fully integrated, specialised pharmaceutical company
with a global network.
- Be a leading source of clinical and commercial innovation
in reproductive endocrinology and urology and a pioneer in Gonadotropin
Releasing Hormone (GNRH) modulation therapeutics.
- Build a broad, balanced pipeline from research to the market
place.
- Be the partner of choice for North American specialty pharmaceutical
companies wishing to enter the reproductive health market in
Europe.
- Market its products to reproductive specialists in Europe
and, in the longer term, the US.
Strategy
Ardana will achieve its objectives by:
- The vigorous pursuit of in-house research and development
programmes.
- Judicious product/company acquisitions, licensing deals and
research collaborations.
- Focusing on secondary care and specialist markets (e.g. endocrinologists,
urologists, obstetricians and gynaecologists) to deliver products
which address underserved areas of reproductive health and that
can be readily accessed by a dedicated specialist sales force
- Commercialising its products across Europe.
- Working with partners to ensure successful sales and marketing
in the US and other markets.
- Adding value to and seeking partners to commercialise non-core
Ardana products and territories and those therapies which address
large, non-specialty markets such as the primary care sector.
|
|
|
